Table 3. Prevalence of Prothrombotic and... | American Society of Hematology

Table 3.

Prevalence of Prothrombotic and Apo E4 Polymorphisms Among Patients With AMI and Controls

No. of Polymorphisms^3-150	AMI Patients		Controls		P^3-151 (χ² test)
No. of Polymorphisms^3-150	No.	%	No.	%	P^3-151 (χ² test)
0	62	55.3	144	77.0	.0003
1	40	35.7	37	19.8
2	10	8.9	6	3.2

No. of Polymorphisms^3-150	AMI Patients		Controls		P^3-151 (χ² test)
No. of Polymorphisms^3-150	No.	%	No.	%	P^3-151 (χ² test)
0	62	55.3	144	77.0	.0003
1	40	35.7	37	19.8
2	10	8.9	6	3.2

Heterozygotes for F V G1691A or F II G20210A; homozygotes for MTHFR 677T and presence of Apo E4.

Relates to the difference between 0 v 1 and ≥2.